Cargando…

Nomograms to predict overall and cancer-specific survival in patients with penile cancer

BACKGROUND: To develop and validate prognostic nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in patients with penile cancer (PC). METHODS: Based on the Surveillance, Epidemiology, and End Result (SEER) database, patients diagnosed with PC from 2010 to 2015 were en...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenbo, Qi, Feng, Liu, Yi, Zheng, Lizhuan, Kang, Zhengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798233/
https://www.ncbi.nlm.nih.gov/pubmed/35117593
http://dx.doi.org/10.21037/tcr.2020.03.77
_version_ 1784641750966468608
author Xu, Wenbo
Qi, Feng
Liu, Yi
Zheng, Lizhuan
Kang, Zhengjun
author_facet Xu, Wenbo
Qi, Feng
Liu, Yi
Zheng, Lizhuan
Kang, Zhengjun
author_sort Xu, Wenbo
collection PubMed
description BACKGROUND: To develop and validate prognostic nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in patients with penile cancer (PC). METHODS: Based on the Surveillance, Epidemiology, and End Result (SEER) database, patients diagnosed with PC from 2010 to 2015 were enrolled in this study. For each patient, clinical characteristics and survival results were respectively collected. With the method of random-number generation, included patients were divided into the training cohort and the validation group. Subsequently, nomograms were constructed to predict 3‐ and 5‐year OS and CSS based on the results of multivariate analyses. Kaplan-Meier (KM) method and the log-rank test were used to estimate survival curves of each variables. Finally, the calibration plots, concordance index (C-index), area under the receiver operating characteristic (ROC) curves were used to evaluate nomograms performance. RESULTS: Totally, 1,418 patients were eventually enrolled in the study, including 994 patients in the training cohort and 424 patients in the validation cohort. No significant difference was detected in the baseline characteristics between two cohorts. According to results of the uni- and multivariate analysis in the training cohort, 7 factors (including age, race, T stage, N stage, M stage, histology codes, and the use of surgery) for OS and 7 factors (including race, T stage, N stage, M stage, histology codes, the use of surgery and lymph node removal) for CSS were selected for constructing the nomograms. The C-indices for OS and CSS were 0.755 and 0.805 in the training cohort and 0.711, 0.737 in the validation cohort. In addition, the 3- and 5-year area under the ROC curve (AUC)s for OS were 0.792 and 0.771 in the training cohort, and 0.687 and 0.695 in the validation group. When it came to CSS, it was 0.83 and 0.826 in the training cohort and 0.758 and 0.746 in the validation cohort. Lastly, the calibration curves indicated a good consistency between the actual survival and the predictive survival. CONCLUSIONS: We firstly established survival models to predict OS and CSS in PC patients with good predictive ability. Further studies are needed to validate our results before clinical application in the future.
format Online
Article
Text
id pubmed-8798233
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87982332022-02-02 Nomograms to predict overall and cancer-specific survival in patients with penile cancer Xu, Wenbo Qi, Feng Liu, Yi Zheng, Lizhuan Kang, Zhengjun Transl Cancer Res Original Article BACKGROUND: To develop and validate prognostic nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in patients with penile cancer (PC). METHODS: Based on the Surveillance, Epidemiology, and End Result (SEER) database, patients diagnosed with PC from 2010 to 2015 were enrolled in this study. For each patient, clinical characteristics and survival results were respectively collected. With the method of random-number generation, included patients were divided into the training cohort and the validation group. Subsequently, nomograms were constructed to predict 3‐ and 5‐year OS and CSS based on the results of multivariate analyses. Kaplan-Meier (KM) method and the log-rank test were used to estimate survival curves of each variables. Finally, the calibration plots, concordance index (C-index), area under the receiver operating characteristic (ROC) curves were used to evaluate nomograms performance. RESULTS: Totally, 1,418 patients were eventually enrolled in the study, including 994 patients in the training cohort and 424 patients in the validation cohort. No significant difference was detected in the baseline characteristics between two cohorts. According to results of the uni- and multivariate analysis in the training cohort, 7 factors (including age, race, T stage, N stage, M stage, histology codes, and the use of surgery) for OS and 7 factors (including race, T stage, N stage, M stage, histology codes, the use of surgery and lymph node removal) for CSS were selected for constructing the nomograms. The C-indices for OS and CSS were 0.755 and 0.805 in the training cohort and 0.711, 0.737 in the validation cohort. In addition, the 3- and 5-year area under the ROC curve (AUC)s for OS were 0.792 and 0.771 in the training cohort, and 0.687 and 0.695 in the validation group. When it came to CSS, it was 0.83 and 0.826 in the training cohort and 0.758 and 0.746 in the validation cohort. Lastly, the calibration curves indicated a good consistency between the actual survival and the predictive survival. CONCLUSIONS: We firstly established survival models to predict OS and CSS in PC patients with good predictive ability. Further studies are needed to validate our results before clinical application in the future. AME Publishing Company 2020-04 /pmc/articles/PMC8798233/ /pubmed/35117593 http://dx.doi.org/10.21037/tcr.2020.03.77 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Xu, Wenbo
Qi, Feng
Liu, Yi
Zheng, Lizhuan
Kang, Zhengjun
Nomograms to predict overall and cancer-specific survival in patients with penile cancer
title Nomograms to predict overall and cancer-specific survival in patients with penile cancer
title_full Nomograms to predict overall and cancer-specific survival in patients with penile cancer
title_fullStr Nomograms to predict overall and cancer-specific survival in patients with penile cancer
title_full_unstemmed Nomograms to predict overall and cancer-specific survival in patients with penile cancer
title_short Nomograms to predict overall and cancer-specific survival in patients with penile cancer
title_sort nomograms to predict overall and cancer-specific survival in patients with penile cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798233/
https://www.ncbi.nlm.nih.gov/pubmed/35117593
http://dx.doi.org/10.21037/tcr.2020.03.77
work_keys_str_mv AT xuwenbo nomogramstopredictoverallandcancerspecificsurvivalinpatientswithpenilecancer
AT qifeng nomogramstopredictoverallandcancerspecificsurvivalinpatientswithpenilecancer
AT liuyi nomogramstopredictoverallandcancerspecificsurvivalinpatientswithpenilecancer
AT zhenglizhuan nomogramstopredictoverallandcancerspecificsurvivalinpatientswithpenilecancer
AT kangzhengjun nomogramstopredictoverallandcancerspecificsurvivalinpatientswithpenilecancer